Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Lazar

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|December 24, 2004
Drug evolution concept in drug design: 1. Hybridization methodCarmen Lazar, Alicja Kluczyk, Taira Kiyota, et al.
Glycoconjugate Journal|October 27, 2010
Specificity of β1,4-galactosyltransferase inhibition by 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-D-glucopyranosideYin Gao, Carmen Lazar, Walter A Szarek, et al.
Journal of the American Chemical Society|November 7, 2002
Detection of chiral perturbations in ferroelectric liquid crystals induced by an atropisomeric biphenyl dopantC Scott Hartley, Carmen Lazar, Michael D Wand, et al.
Bioorganic & Medicinal Chemistry|July 17, 2010
Anti-Plasmodium activity of imidazolium and triazolium saltsJason Z Vlahakis, Carmen Lazar, Ian E Crandall, et al.
Chemmedchem|March 21, 2012
Heme oxygenase inhibition by α-(1H-imidazol-1-yl)-ω-phenylalkanes: effect of introduction of heteroatoms in the alkyl linkerJason Z Vlahakis, Carmen Lazar, Gheorghe Roman, et al.
Current Medicinal Chemistry|October 9, 2002
Drug evolution: p-aminobenzoic acid as a building blockAlicja Kluczyk, Tomasz Popek, Taira Kiyota, et al.
SAGE Open Nursing|March 11, 2026
BOOST 2.0: Feasibility of Using the Nursing Student Workforce to Increase Activity: A Qualitative StudyAnnabel Darmali, Seema Radhakrishnan, Christina Eagleton, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|December 24, 2004
Drug evolution concept in drug design: 1. Hybridization methodCarmen Lazar, Alicja Kluczyk, Taira Kiyota, et al.
Glycoconjugate Journal|October 27, 2010
Specificity of β1,4-galactosyltransferase inhibition by 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-D-glucopyranosideYin Gao, Carmen Lazar, Walter A Szarek, et al.
Journal of the American Chemical Society|November 7, 2002
Detection of chiral perturbations in ferroelectric liquid crystals induced by an atropisomeric biphenyl dopantC Scott Hartley, Carmen Lazar, Michael D Wand, et al.
Bioorganic & Medicinal Chemistry|July 17, 2010
Anti-Plasmodium activity of imidazolium and triazolium saltsJason Z Vlahakis, Carmen Lazar, Ian E Crandall, et al.
Chemmedchem|March 21, 2012
Heme oxygenase inhibition by α-(1H-imidazol-1-yl)-ω-phenylalkanes: effect of introduction of heteroatoms in the alkyl linkerJason Z Vlahakis, Carmen Lazar, Gheorghe Roman, et al.
Current Medicinal Chemistry|October 9, 2002
Drug evolution: p-aminobenzoic acid as a building blockAlicja Kluczyk, Tomasz Popek, Taira Kiyota, et al.
SAGE Open Nursing|March 11, 2026
BOOST 2.0: Feasibility of Using the Nursing Student Workforce to Increase Activity: A Qualitative StudyAnnabel Darmali, Seema Radhakrishnan, Christina Eagleton, et al.
Pageof 1